{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:55:49Z","timestamp":1791608149160,"version":"4.3.4"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1001\/jamaophthalmol.2018.4973","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T21:35:27Z","timestamp":1540244127000},"page":"1391","source":"Crossref","is-referenced-by-count":11,"title":["Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion"],"prefix":"10.1001","volume":"136","author":[{"given":"Ian L.","family":"McAllister","sequence":"first","affiliation":[{"name":"Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Department of Ophthalmology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne A.","family":"Smithies","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred K.","family":"Chen","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Department of Ophthalmology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Mackey","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Sanfilippo","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"eoi180090r1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi180090r2","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","article-title":"Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi180090r3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ajo.2012.09.026","article-title":"Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.","volume":"155","author":"Brown","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"eoi180090r4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ophtha.2011.12.005","article-title":"Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi180090r5","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ophtha.2014.01.027","article-title":"Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study.","volume":"121","author":"Heier","year":"2014","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi180090r6","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0161-6420(95)30848-2","article-title":"A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N report.","volume":"102","author":"The Central Vein Occlusion Study Group","year":"1995","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi180090r7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/archopht.1995.01100040072030","article-title":"Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion.","volume":"113","author":"McAllister","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"eoi180090r8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0002-9394(98)00156-1","article-title":"Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors.","volume":"126","author":"McAllister","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"eoi180090r9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ophtha.2009.10.026","article-title":"The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion.","volume":"117","author":"McAllister","year":"2010","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi180090r10","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.ophtha.2012.06.047","article-title":"Factors promoting success and influencing complications in laser-induced central vein bypass.","volume":"119","author":"McAllister","year":"2012","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi180090r11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","article-title":"Vascular endothelial growth factor upregulation in human central retinal vein occlusion.","volume":"105","author":"Pe\u2019er","year":"1998","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi180090r12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00417-003-0643-7","article-title":"Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with retinal vein stasis or occlusion.","volume":"241","author":"Jonas","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"eoi180090r13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ajo.2006.09.019","article-title":"Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusion.","volume":"143","author":"Jonas","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"20","key":"eoi180090r14","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"eoi180090r15","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1097\/IAE.0000000000001025","article-title":"Technique of laser chorioretinal anastomosis creation in central retinal vein occlusion and success rate with a new photocoagulator system.","volume":"36","author":"McAllister","year":"2016","journal-title":"Retina"},{"issue":"2","key":"eoi180090r16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.oret.2017.05.016","article-title":"Sustained benefits from ranibizumab for central retinal vein occlusion with macular edema: 24-month results of the CRYSTAL study.","volume":"2","author":"Larsen","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"eoi180090r17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/02713689508999915","article-title":"Optimal conditions required for the creation of an iatrogenic chorioretinal venous anastomosis in the dog using argon green laser photocoagulation.","volume":"14","author":"Vijayasekaran","year":"1995","journal-title":"Curr Eye Res"},{"issue":"4","key":"eoi180090r18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion.","volume":"115","author":"The Central Vein Occlusion Study Group","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"eoi180090r19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ajo.2012.03.047","article-title":"Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.","volume":"154","author":"Krohne","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"eoi180090r20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1006\/exer.1996.0239","article-title":"Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates.","volume":"64","author":"Ozaki","year":"1997","journal-title":"Exp Eye Res"},{"issue":"5","key":"eoi180090r21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.ajo.2008.12.006","article-title":"Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.","volume":"147","author":"McAllister","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"eoi180090r22","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.ophtha.2014.05.031","article-title":"The effect of central retinal venous pressure in patients with central retinal vein occlusion and a high mean area of nonperfusion.","volume":"121","author":"McAllister","year":"2014","journal-title":"Ophthalmology"},{"issue":"14","key":"eoi180090r23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"eoi180090r24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration.","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"eoi180090r25","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.ophtha.2015.02.009","article-title":"Two-year outcomes of \u201ctreat and extend\u201d intravitreal therapy for neovascular age-related macular degeneration.","volume":"122","author":"Arnold","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi180090r26","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ophtha.2013.11.031","article-title":"The neovascular age-related macular degeneration database: multicenter study of 92?976 ranibizumab injections: report 1: visual acuity.","volume":"121","author":"Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi180090r27","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.ophtha.2010.03.060","article-title":"Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi180090r28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ophtha.2010.04.019","article-title":"Natural history of visual outcome in central retinal vein occlusion.","volume":"118","author":"Hayreh","year":"2011","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi180090r29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/ceo.2009.37.issue-5","article-title":"Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion.","volume":"37","author":"Fong","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"eoi180090r30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3111\/13696998.2014.909435","article-title":"A United Kingdom\u2013based economic evaluation of ranibizumab for patients with retinal vein occlusion (RVO).","volume":"17","author":"Taylor","year":"2014","journal-title":"J Med Econ"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2707252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T16:22:31Z","timestamp":1544718151000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.4973"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.4973","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}